%0 Journal Article %T Efficacy and Patient Satisfaction of Dipeptidyl Peptidase-4 Inhibitor After Switching From Once-Daily DPP-4 Inhibitor to Once-Weekly Regimen %A Katsunori Suzuki %A Kazuki Hasegawa %A Mio Watanabe %J Journal of Clinical Medicine Research %D 2018 %R https://doi.org/10.14740/jocmr3456w %X Background: We administered once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor (W) (used omarigliptin as W in this study) to patients with type 2 diabetes taking once-daily DPP-4 inhibitor (D), and investigated efficacy, safety and patient satisfaction before and after switching to W. %U https://www.jocmr.org/index.php/JOCMR/article/view/3456